Literature DB >> 10497299

Hepatitis B virus in hepatocarcinogenesis.

M A Feitelson1.   

Abstract

Hepatitis B virus (HBV) is an important etiologic agent of chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Although the mechanism whereby HBV causes HCC is not fully understood, it is likely that there are many relevant molecular pathways that contribute to the development of HBV-associated HCC. This review provides an overview of some of these proposed pathways and their relative importance. It also raises questions on basic and translational research that will signficantly contribute to the better understanding of underlying mechanisms, prevention, and treatment of this tumor type. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10497299     DOI: 10.1002/(SICI)1097-4652(199911)181:2<188::AID-JCP2>3.0.CO;2-7

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  29 in total

1.  Anti-HBV hairpin ribozyme-mediated cleavage of target RNA in vitro.

Authors:  Yu-Hu Song; Ju-Sheng Lin; Nan-Zhi Liu; Xin-Juan Kong; Na Xie; Nan-Xia Wang; You-Xin Jin; Kuo-Huan Liang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated.

Authors:  Xu Lin; Xiao Xu; Qing-Ling Huang; Yu-Qing Liu; Da-Li Zheng; Wan-Nan Chen; Jian-Yin Lin
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

Review 3.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

4.  Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells.

Authors:  K A Shera; C A Shera; J K McDougall
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis.

Authors:  Kathryn L Nash; Tracy Woodall; Ashley S M Brown; Susan E Davies; Graeme J M Alexander
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

Review 6.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

7.  Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles.

Authors:  Marshonna Forgues; Michael J Difilippantonio; Steven P Linke; Thomas Ried; Kunio Nagashima; Jeffrey Feden; Kristoffer Valerie; Kenji Fukasawa; Xin W Wang
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

8.  Anti-HBV effect of TAT- HBV targeted ribonuclease.

Authors:  Jin Ding; Jun Liu; Cai-Fang Xue; Wei-Dong Gong; Ying-Hui Li; Ya Zhao
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 9.  Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis.

Authors:  Yasunobu Matsuda; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

10.  Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells.

Authors:  Lian Yang; Jun He; Libo Chen; Guobin Wang
Journal:  Med Oncol       Date:  2008-12-13       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.